Working with our members, Cancer52 has looked at the progress that has been made for people with rare and less common cancers against the NHS Long Term Plan since it was published just over a year ago. Our findings and recommendations are published in our report Gettin...
Available from 6th December 2016 to mark the Cancer52 session at Britain Against Cancer – a new report from Cancer52 on the role of the CNS in rare and less common cancers – some personal perspectives from patients and nurses.
Our new patient experience report - what does the evidence from the National Cancer Patient Experience Survey show us about experience of people with a rare or less common cancer? What is it that can make the difference to that experience?
A new report on patient group involvement in the new Patient and Clinical Engagement (PACE) process at the Scottish Medicines Consortium (SMC) – what can we learn from these experiences and what can we share?
We are delighted to announce that our new report “Rare and Less Common Cancers: Incidence and Mortality in England, 2010 to 2013” is published today (Monday 8th June 2015) on the first day of the NCIN conference in Belfast. It is a report produced jointly by Cancer52 a...
A new report published today (Tuesday 10th June 2014) by Cancer52 shows that the percentage of cancer deaths from those cancers outside the 'big four' (of breast, bowel, prostate and lung) is rising with a new high of 54% recorded in 2011.
The National Cancer Research Institute (NCRI) and Cancer52 have published a report "Research into less common cancers". It shows for the first time the level and type of research investment in rare and less common cancers by members of Cancer52.